Alzamend Neuro (ALZN)

Alzamend Neuro (ALZN) Financial Statements


Alzamend Neuro Financial Overview

Alzamend Neuro's market cap is currently ―. The company's EPS TTM is $-0.132; its P/E ratio is -4.69; Alzamend Neuro is scheduled to report earnings on March 15, 2022, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Oct 22Jul 22Apr 22Jan 22Oct 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -3.11M$ -3.04M$ -3.87M$ -2.56M$ -3.58M
EBITDA$ -3.10M$ -3.03M$ -3.87M$ -2.56M$ -3.58M
Net Income Common Stockholders$ -3.11M$ -3.04M$ -3.87M$ -2.57M$ -3.60M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 9.18M$ 11.53M$ 14.06M$ 11.79M$ 13.57M
Total Assets$ 10.42M$ 12.21M$ 14.52M$ 12.43M$ 14.50M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 344.89K
Net Debt$ -9.18M$ -11.53M$ -14.06M$ -11.79M$ -13.23M
Total Liabilities$ 1.64M$ 1.03M$ 1.16M$ 466.98K$ 1.48M
Stockholders Equity$ 8.79M$ 11.18M$ 13.35M$ 11.96M$ 13.03M
Cash Flow
Free Cash Flow$ -2.34M$ -2.54M$ -1.67M$ -1.78M$ -2.05M
Operating Cash Flow$ -2.34M$ -2.54M$ -1.56M$ -1.78M$ -2.05M
Investing Cash Flow$ ―$ ―$ -106.46K$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 0.00$ 3.94M$ 400.00$ 700.00
Currency in USD

Alzamend Neuro Earnings and Revenue History

Alzamend Neuro Debt to Assets

Alzamend Neuro Cash Flow

Alzamend Neuro Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis